NCT04830540

Brief Summary

The goal of this study is to understand the impact of wearing shoes with a compliant, energy absorbing midsole material, outside of athletic training sessions on the mechanics of movement, performance, and perceived joint pain and stiffness. Advances in material science have led to a wider range of cushioning system material properties and mid and outsole geometries in footwear. While there are many marketing claims about the potential health benefits of this new class of footwear these have not yet been investigated in well-designed scientific studies. It is hypothesized that the intervention shoe as compared to the control will reduce self-reported joint pain and stiffness, improve ankle plantarflexion function and increase intersegmental foot motion during walking.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2021

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

March 5, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 5, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
Last Updated

April 5, 2021

Status Verified

February 1, 2021

Enrollment Period

12 months

First QC Date

March 5, 2021

Last Update Submit

April 1, 2021

Conditions

Outcome Measures

Primary Outcomes (16)

  • Calf Muscles Strength

    Unilateral isometric and isokinetic strength based on maximal contractions performed on a dynamometer.

    2 - 3 hours on week 1

  • Calf Muscles Strength

    Unilateral isometric and isokinetic strength based on maximal contractions performed on a dynamometer.

    2 - 3 hours on week 6.

  • Gait Mechanics

    Gait kinematics during overground walk at preferred speed, and 1.4m/s, evaluated with a motion capture system.

    Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s

  • Gait Mechanics

    Gait kinematics during overground walk at preferred speed, and 1.4m/s, evaluated with a motion capture system.

    Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s

  • Muscle EMG activity

    Unilateral Surface Electromyography of Medial Gastrocnemius, Lateral Gastrocnemius, Vastus Medialis, Vastus Lateralis, Tibialis Anterior, Peroneus Longus, Soleus, Biceps Femoris, and Semitendinosus, during overground walk.

    Gait analysis test at week 1 with 5 trials of overground walking at a speed of 1.4 m/s

  • Muscle EMG activity

    Unilateral Surface Electromyography of Medial Gastrocnemius, Lateral Gastrocnemius, Vastus Medialis, Vastus Lateralis, Tibialis Anterior, Peroneus Longus, Soleus, Biceps Femoris, and Semitendinosus, during overground walk.

    Gait analysis test at week 6 with 5 trials of overground walking at a speed of 1.4 m/s

  • Maximum Vertical Jump

    Height (m) of center of mass above ground measured by markers place on posterior superior iliac spine.

    2 - 3 hours on week 1

  • Maximum Vertical Jump

    Height (m) of center of mass above ground measured by markers place on posterior superior iliac spine.

    2 - 3 hours on week 6

  • Self-reported shoe comfort

    Shoe wear and comfort log

    Week 0, 5 minutes

  • Self-reported pain, and injury.

    Injury and pain log

    Week 0, 5 minutes

  • Self-reported shoe comfort

    Shoe wear and comfort log

    Week 2, 5 minutes

  • Self-reported pain, and injury.

    Injury and pain log

    Week 2, 5 minutes

  • Self-reported shoe comfort

    Shoe wear and comfort log

    Week 4, 5 minutes

  • Self-reported pain, and injury.

    Injury and pain log

    Week 4, 5 minutes

  • Self-reported shoe comfort

    Shoe wear and comfort log

    Week 6, 5 minutes

  • Self-reported pain, and injury.

    Injury and pain log

    Week 6, 5 minutes

Study Arms (2)

Control

NO INTERVENTION

Participants assigned to the control group will be asked to continue wearing their typical shoes and to complete every two weeks the footwear and injury log provided

Intervention

EXPERIMENTAL

Individuals assigned to the intervention group will be provided with 2 styles of the OOFOS recovery shoes, and will be asked to wear the OOFOS slide, sandal and/or closed toe shoes as their primary footwear outside training and competition for the 6 weeks between study visits. Intervention participants will also be asked to complete a daily shoe wear log and a shoe comfort assessment survey every other week.

Device: OOFOS Recovery Footwear

Interventions

The OOFOS shoes/ sandals are a commercially available footwear with a compliant, energy absorbing midsole material.

Intervention

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI 18 - 35 kg/m2.
  • Stiff or cleated footwear athlete on a competitive team.

You may not qualify if:

  • Current injury that required absence from one or more practices in the last 3 weeks of regular team practice.
  • Orthotic or other shoe insert used outside of athletic training times.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Musculoskeletal & Orthopedic Biomechanics Laboratory/ University of Massachusetts Amherst

Amherst, Massachusetts, 01002, United States

RECRUITING

MeSH Terms

Conditions

Arthralgia

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2021

First Posted

April 5, 2021

Study Start

February 8, 2021

Primary Completion

January 31, 2022

Study Completion

January 31, 2022

Last Updated

April 5, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations